Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
55
AKRO Quote, Financials, Valuation and Earnings
Last price:
$54.65
Seasonality move
:
1.27%
Day range:
$54.65 - $54.65
52-week range:
$21.34 - $58.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.70x
Volume:
--
Avg. volume:
1.7M
1-year change:
90.35%
Market cap:
$4.5B
Revenue:
--
EPS (TTM):
-$3.75
Earnings Data
Next earnings date for AKRO
Feb 27
2026
Most recent earnings per share
-$0.99
Missed by $0.06
(Nov 10/2025)
Consensus Estimate
-$0.93
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AKRO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/27/2026 | Q4 | -- | -- | -- | -$0.89 | -- |
| 11/10/2025 | Q3 | -- | -- | -$0.99 | -$0.93 | -$0.06 |
| 08/08/2025 | Q2 | -- | -- | -$0.86 | -$0.90 | $0.04 |
| 05/12/2025 | Q1 | -- | -- | -$0.90 | -$0.99 | $0.09 |
| 02/28/2025 | Q4 | -- | -- | -$0.99 | -$1.12 | $0.13 |
| 11/08/2024 | Q3 | -- | -- | -$1.05 | -$0.93 | -$0.12 |
| 08/09/2024 | Q2 | -- | -- | -$0.81 | -$0.89 | $0.08 |
| 05/10/2024 | Q1 | -- | -- | -$0.90 | -$0.93 | $0.03 |
| 02/29/2024 | Q4 | -- | -- | -$1.02 | -$0.83 | -$0.19 |
| 11/13/2023 | Q3 | -- | -- | -$0.71 | -$0.69 | -$0.02 |
| 08/11/2023 | Q2 | -- | -- | -$0.60 | -$0.71 | $0.11 |
| 05/15/2023 | Q1 | -- | -- | -$0.55 | -$0.64 | $0.09 |
| 03/17/2023 | Q4 | -- | -- | -$0.49 | -$0.83 | $0.34 |
| 11/04/2022 | Q3 | -- | -- | -$0.92 | -$0.73 | -$0.19 |
| 08/05/2022 | Q2 | -- | -- | -$0.77 | -$0.86 | $0.09 |
| 05/06/2022 | Q1 | -- | -- | -$0.74 | -$0.84 | $0.10 |
| 02/25/2022 | Q4 | -- | -- | -$0.93 | -$0.81 | -$0.12 |
| 11/12/2021 | Q3 | -- | -- | -$0.70 | -$0.91 | $0.21 |
| 08/13/2021 | Q2 | -- | -- | -$0.83 | -$0.71 | -$0.12 |
| 05/13/2021 | Q1 | -- | -- | -$0.43 | -$0.94 | $0.51 |
| 03/16/2021 | Q4 | -- | -- | -$0.86 | -$0.60 | -$0.26 |
| 11/12/2020 | Q3 | -- | -- | -$0.63 | -$0.67 | $0.04 |
| 08/12/2020 | Q2 | -- | -- | -$0.57 | -$0.62 | $0.05 |
| 05/13/2020 | Q1 | -- | -- | -$0.42 | -$0.61 | $0.19 |
| 03/16/2020 | Q4 | -- | -- | -$0.55 | -$0.58 | $0.03 |
| 11/12/2019 | Q3 | -- | -- | -$0.56 | -$0.43 | -$0.13 |
| 08/12/2019 | Q2 | -- | -- | -$0.26 | -$0.36 | $0.10 |
Akero Therapeutics, Inc. Earnings Questions
-
How Much did Akero Therapeutics, Inc. Generate in Revenue Last Quarter?
Akero Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Akero Therapeutics, Inc. Beat Earnings Last Quarter?
Akero Therapeutics, Inc. announced earnings per share of -$0.99 which represents a miss of analyst forecast a -$0.93 per share.
-
Is Akero Therapeutics, Inc. Profitable?
Akero Therapeutics, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Akero Therapeutics, Inc. EPS Next Year?
Akero Therapeutics, Inc.'s earnings are forecast to decrease from -$3.75 per share to -$3.95 per share next year representing a decrease of -1.52%.
-
When is Akero Therapeutics, Inc.'s Earnings Date?
Akero Therapeutics, Inc.'s next earnings date is February 27, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
